Medtronic-Hall valve: thromboembolic complications

Area of Science:

• Cardiovascular Surgery
• Biomaterials Science

Background:

• Mechanical heart valves, such as the Medtronic-Hall prosthesis, are used to replace damaged valves.
• Thromboembolic complications remain a significant concern following valve replacement surgery.

Purpose of the Study:

• To investigate the incidence of thromboembolic complications in patients with Medtronic-Hall prostheses.
• To identify risk factors associated with these complications in mitral and aortic positions.
• To evaluate the impact of aspirin on complication rates.

Main Methods:

• Retrospective study of 46 patients with Medtronic-Hall prostheses (21 mitral, 25 aortic).
• Analysis of pre-defined thromboembolic risk factors.
• Comparison of complication rates between valve positions and impact of aspirin therapy.

Main Results:

• Overall thromboembolic complication rates were 23.8% (mitral) and 24% (aortic).
• In mitral position, risk factors included prior thromboembolism, previous surgeries, atrial fibrillation, and postoperative heart failure/low output.
• In aortic position, only postoperative low output syndrome correlated with complications; aspirin reduced incidence from 26% to 16%.

Conclusions:

• Thromboembolic complication rates, while seemingly high, are influenced by patient clinical circumstances.
• Aspirin therapy demonstrates a significant benefit in reducing thromboembolic events in aortic position Medtronic-Hall prosthesis recipients.